November 11, 2022
Via: PharmaphorumThe European Commission has backed the use of the companies’ adjuvanted VidPrevtyn Beta vaccine – which targets the Beta variant of SARS-CoV-2 – as a booster vaccine candidate on the back of two “immunobridging” trials comparing it with currently-approved jabs. […]